Zobrazeno 1 - 10
of 46
pro vyhledávání: '"T. C., Kok"'
Publikováno v:
Malaysian Dental Journal; Jul-Dec2023, Vol. 46 Issue 2, p9-24, 16p
Autor:
M.L. Couvreur, B Genicot, Geert H. Blijham, J. De Greve, Harry Bleiberg, Benoit Baron, Jaques Wils, Johan W.R. Nortier, T. C. Kok, Th. Wagener, R.L.H Jansen
Publikováno v:
European Journal of Cancer. 39:346-352
The aim of this study was to investigate whether N-(phosphonacetyl)-L-aspartic acid (PALA) can enhance the activity of low-dose methotrexate (LD-MTX) modulated infusional 5-fluorouracil (5-FU) in patients with advanced colorectal cancer. 198 patients
Autor:
Wim C. J. Hop, Peter D. Siersema, M. B. Polee, Gerrit Stoter, T. C. Kok, H. W. Tilanus, Ferry A.L.M. Eskens, M.E.L. van der Burg, A. van der Gaast, Ted A.W. Splinter
Publikováno v:
British Journal of Cancer
British Journal of Cancer, 89, 2045-2050. Nature Publishing Group
British Journal of Cancer, 89, 2045-2050. Nature Publishing Group
The objective of this study was to identify prognostic factors for survival in patients with advanced oesophageal cancer, who are treated with cisplatin-based combination chemotherapy. We analysed the baseline characteristics of 350 patients who were
Autor:
Peter D. Siersema, Herman van Dekken, Hugo W. Tilanus, T. C. Kok, Ate van der Gaast, Mariska Hage, Ernst J. Kuipers
Publikováno v:
European Journal of Gastroenterology & Hepatology, 14, 1261-1264. Lippincott Williams & Wilkins
The prognosis of patients with oesophageal cancer is poor, with an overall 5-year survival rate below 15%. The best chance for cure of patients with oesophageal cancer is surgical resection. However, more than 50% of patients have inoperable disease
Autor:
G. Stoter, A. van der Gaast, Peter D. Siersema, Ted A.W. Splinter, M. B. Polee, H. W. Tilanus, T. C. Kok
Publikováno v:
Anti-Cancer Drugs, 12(6), 513-517. Lippincott Williams & Wilkins
The objective of this study was to determine the toxicity and the efficacy of the combination of cisplatin, etoposide, 5-fluorouracil (5-FU) and folinic acid in the treatment of patients with advanced squamous cell carcinoma of the esophagus. Patient
Publikováno v:
European Journal of Cancer, 33(11), 1865-1868. Elsevier Ltd.
European Journal of Cancer, 33, 1865-1868. Elsevier
European Journal of Cancer, 33, 1865-1868. Elsevier
Controversial results regarding the presence and role of human papillomavirus in the development of oesophageal squamous cell carcinoma have been published. We used multiple broad-spectrum polymerase chain reactions to identify HPV DNA in oesophageal
Autor:
H. W. Tilanus, H. Van Overhagen, T. C. Kok, G. Stoter, A. van der Gaast, Jan Dees, W. M. H. Eykenboom, Ted A.W. Splinter
Publikováno v:
British Journal of Cancer. 74:980-984
In the search for effective chemotherapy regimens which can be used in multimodality treatment programmes for patients with cancer of the oesophagus, we conducted a phase II trial to determine the activity and toxicity of the combination of cisplatin
Autor:
T. C. Kok, Ted A.W. Splinter, B. G. Blijenberg, C. H. H. Schoenmakers, A. van der Gaast, F. Cornillie
Publikováno v:
British Journal of Cancer
The Cyfra 21.1 assay is a newly developed test which measures in serum a fragment of cytokeratin 19. We evaluated this marker in 212 patients with non-small-cell lung cancer (NSCLC), predominantly stage 3a-b and 4, and compared it with three other ma
Autor:
Bas P. L. Wijnhoven, J. Jan B. van Lanschot, Ate van der Gaast, Jurjen J. Boonstra, T. C. Kok, Peter D. Siersema, Hugo W. Tilanus, Fiebo J.W. ten Kate, Winand N.M. Dinjens, Mark van Heijl, Mark I. van Berge Henegouwen
Publikováno v:
BMC Cancer, 11. BioMed Central Ltd.
BMC Cancer
BMC Cancer, Vol 11, Iss 1, p 181 (2011)
BMC Cancer, 11(1). BioMed Central
BMC cancer, 11(1). BioMed Central
BMC Cancer
BMC Cancer, Vol 11, Iss 1, p 181 (2011)
BMC Cancer, 11(1). BioMed Central
BMC cancer, 11(1). BioMed Central
Background This is a randomized, controlled trial of preoperative chemotherapy in patients undergoing surgery for oesophageal squamous cell carcinoma (OSCC). Patients were allocated to chemotherapy, consisting of 2-4 cycles of cisplatin and etoposide
Publikováno v:
Endoscopy. 25:592-596
Endoscopic ultrasonography (EUS) is currently considered the best available technique for the local staging of esophageal cancer. In a prospective study 11 patients with esophageal squamous cell carcinoma were investigated to evaluate the usefulness